- Home
- PCRX vs PL Comparison
PCRX vs PL Comparison
Compare PCRX & PL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- PL
- Stock Information
- Founded
- PCRX 2006
- PL 2010
- Country
- PCRX United States
- PL United States
- Employees
- PCRX N/A
- PL N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- PL Aerospace
- Sector
- PCRX Health Care
- PL Industrials
- Exchange
- PCRX Nasdaq
- PL Nasdaq
- Market Cap
- PCRX 1.1B
- PL 1.0B
- IPO Year
- PCRX 2011
- PL N/A
- Fundamental
- Price
- PCRX $24.91
- PL $3.44
- Analyst Decision
- PCRX Buy
- PL Strong Buy
- Analyst Count
- PCRX 9
- PL 11
- Target Price
- PCRX $30.67
- PL $5.79
- AVG Volume (30 Days)
- PCRX 920.6K
- PL 4.7M
- Earning Date
- PCRX 05-06-2025
- PL 03-20-2025
- Dividend Yield
- PCRX N/A
- PL N/A
- EPS Growth
- PCRX N/A
- PL N/A
- EPS
- PCRX N/A
- PL N/A
- Revenue
- PCRX $700,966,000.00
- PL $244,352,000.00
- Revenue This Year
- PCRX $9.77
- PL $15.78
- Revenue Next Year
- PCRX $9.83
- PL $17.22
- P/E Ratio
- PCRX N/A
- PL N/A
- Revenue Growth
- PCRX 3.85
- PL 10.72
- 52 Week Low
- PCRX $11.16
- PL $1.67
- 52 Week High
- PCRX $31.67
- PL $6.71
- Technical
- Relative Strength Index (RSI)
- PCRX 55.86
- PL 37.38
- Support Level
- PCRX $23.93
- PL $3.15
- Resistance Level
- PCRX $25.08
- PL $4.03
- Average True Range (ATR)
- PCRX 0.97
- PL 0.25
- MACD
- PCRX 0.20
- PL -0.00
- Stochastic Oscillator
- PCRX 76.05
- PL 41.78
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About PL Planet Labs PBC
Planet Labs PBC is an Earth-imaging company. The company provides daily satellite data that helps businesses, governments, researchers, and journalists understand the physical world and take action.